Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 27,000 PBYI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |
| May 20, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 5,750 | n/a |
| Feb 3, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 12,000 | n/a |
| Jan 13, 2026 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 17,000 | n/a |
| Nov 13, 2025 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 20,000 | $97.2K |
| Jun 13, 2025 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |
| Aug 13, 2024 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 23,358 | $81.5K |
| Jun 21, 2024 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |
| Jun 11, 2024 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 17,000 | n/a |
| Nov 9, 2023 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 25,000 | $70.8K |